# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA673517 | F | The compound was evaluated for the growth inhibition of Dx5 cell lines using MTT assay. | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
2. | ALA673518 | F | The compound was evaluated for the growth inhibition of Dx5 w/PSC cell lines using MTT assay. | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
3. | ALA710065 | F | Cell growth inhibition against MES-SA human uterine cancer cells using MTS assay | Homo sapiens | 16 | cell-based format | Scientific Literature | ||
4. | ALA711532 | F | In vitro cytotoxic activity against uterine sarcoma (MES-SA) cells assayed by inhibition of [3H]-labeled thymidine incorporation | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
5. | ALA711692 | F | In vitro cytotoxic activity against uterine sarcoma (MES-SA) cells assayed by inhibition of [3H]-labeled thymidine incorporation; Not calculable | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
6. | ALA711693 | F | Tested for inhibition of cell proliferation activity in human uterus sarcoma MES-SA cell | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
7. | ALA713910 | F | In vitro anticancer activity against human uterus MES-SA cells | Homo sapiens | 18 | cell-based format | Scientific Literature | ||
8. | ALA713913 | F | Tested for inhibition of cell proliferation activity in doxorubicin resistant human uterus sarcoma MES-SA/DX5 cell | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
9. | ALA713914 | F | Compound (1 uM) was evaluated for the inhibition of cell growth in MES-SA/DX5 cell line (over expresses Pgp and is Doxorubicin resistant) in the presence of doxorubicin | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
10. | ALA713915 | F | Compound (1 uM) was evaluated for the inhibition of cell growth in MES-SA/DX5 cell line (over expresses Pgp and is for Doxorubicin resistant) in the presence of taxol | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
11. | ALA713916 | F | Compound (1 uM) was evaluated for the inhibition of cell growth in MES-SA/DX5** cell line (over expresses Pgp and is for Doxorubicin resistant) in the presence of doxorubicin | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
12. | ALA713917 | F | Compound (1 uM) was evaluated for the inhibition of cell growth in MES-SA/DX5** cell line (over expresses Pgp and is for Doxorubicin resistant) in the presence of taxol | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
13. | ALA713920 | F | In vitro anticancer activity against human uterus MES-SA/DX5 subline (doxorubicin-resistant) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
14. | ALA713921 | F | In vitro anticancer activity against human uterus MES-SA/Dx5 subline (doxorubicin-resistant) | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
15. | ALA713922 | F | Cell growth inhibition against,MES-SA/DX5 human uterine cancer cells using MTS assay | Homo sapiens | 16 | cell-based format | Scientific Literature | ||
16. | ALA862992 | F | Cytotoxicity against human uterine sarcoma, MES-SA-Dx5 cells derived from MES-SA | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
17. | ALA907428 | F | Antiproliferative activity against doxorubicin-resistant MES-SA/Dx5 cells by MTT assay after 72 hrs | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
18. | ALA907429 | F | Resistant factor, IC50 for MES-SA/Dx5/ IC50 for MES-SA cells by MTT assay after 72 hrs | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
19. | ALA908086 | F | Cytotoxicity against human MES-SA/DX5 cell line by MTS assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
20. | ALA907747 | F | Cytotoxicity against MES-SA/dx5 cell line by WST1 assay | Homo sapiens | 2 | cell-based format | Scientific Literature |